Putting protein motion at the heart of drug discovery to expand therapeutic possibilities51-200 Employees

B2B
Public Stage
Publicly traded company
Top Investors
This company has received a significant amount of investment from top investors
5.0
Highly rated
Relay Therapeutics is highly rated on Glassdoor, with 5.0 out of 5 stars
4.8
Work / Life Balance
Employees rate Relay Therapeutics 4.8/5 on Glassdoor for work / life balance
5.0
Strong Leadership
Employees rate Relay Therapeutics 5.0/5 on Glassdoor for faith in leadership

Relay Therapeutics careers

Putting protein motion at the heart of drug discovery to expand therapeutic possibilities

Relay Therapeutics is building the world’s first dedicated drug discovery platform centered on protein motion to discover and develop new medicines that will make a transformative difference for patients. By placing protein motion at the heart of drug discovery, Relay is pursuing what it believes will be a fundamental paradigm shift within the pharmaceutical industry, ushering in a new generation of drugs with the potential to improve and extend the lives of millions of patients.

Headquartered in Cambridge, Mass., Relay Therapeutics is a private company launched in 2016. To date, Relay Therapeutics has raised $120M in financing from Third Rock Ventures, BVF Partners, GV (formerly Google Ventures), an affiliate of D.E. Shaw Research, Casdin Capital, EcoR1 Capital, Section 32 and Alexandria Venture Investments.

Jobs

View all jobs